Irene Feingold

740 total citations
17 papers, 449 citations indexed

About

Irene Feingold is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Irene Feingold has authored 17 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Surgery and 7 papers in Oncology. Recurrent topics in Irene Feingold's work include Cholesterol and Lipid Metabolism (10 papers), Drug Transport and Resistance Mechanisms (7 papers) and Estrogen and related hormone effects (6 papers). Irene Feingold is often cited by papers focused on Cholesterol and Lipid Metabolism (10 papers), Drug Transport and Resistance Mechanisms (7 papers) and Estrogen and related hormone effects (6 papers). Irene Feingold collaborates with scholars based in Canada and United States. Irene Feingold's co-authors include Jay Wrobel, Elaine Quinet, Ponnal Nambi, Annika Goos‐Nilsson, Anna Wilhelmsson, Mark J. Evans, Christine Huselton, Howard D. Colby, Robert J. Steffan and Michael Basso and has published in prestigious journals such as Circulation, Journal of Medicinal Chemistry and Journal of Lipid Research.

In The Last Decade

Irene Feingold

17 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Irene Feingold Canada 12 194 191 162 139 39 17 449
Anna Wilhelmsson Sweden 12 215 1.1× 229 1.2× 203 1.3× 118 0.8× 44 1.1× 19 481
Paul K. Spearing United States 9 110 0.6× 208 1.1× 242 1.5× 154 1.1× 121 3.1× 16 559
Colin J. Theobald United Kingdom 13 107 0.6× 243 1.3× 33 0.2× 142 1.0× 31 0.8× 18 464
JeanMarie Lisnock United States 9 87 0.4× 315 1.6× 88 0.5× 110 0.8× 7 0.2× 12 542
Alan D. Adams United States 14 262 1.4× 483 2.5× 182 1.1× 104 0.7× 39 1.0× 16 766
Harold E. Osborne United States 9 67 0.3× 217 1.1× 85 0.5× 69 0.5× 168 4.3× 11 455
Kazuyoshi Tomita Japan 10 92 0.5× 158 0.8× 33 0.2× 80 0.6× 16 0.4× 19 379
Annika Goos‐Nilsson United States 11 128 0.7× 152 0.8× 119 0.7× 148 1.1× 51 1.3× 19 377
Tomoyuki Fujioka Japan 10 99 0.5× 166 0.9× 28 0.2× 74 0.5× 7 0.2× 17 357
Lena Schultz United States 11 38 0.2× 363 1.9× 61 0.4× 100 0.7× 52 1.3× 18 617

Countries citing papers authored by Irene Feingold

Since Specialization
Citations

This map shows the geographic impact of Irene Feingold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irene Feingold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irene Feingold more than expected).

Fields of papers citing papers by Irene Feingold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irene Feingold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irene Feingold. The network helps show where Irene Feingold may publish in the future.

Co-authorship network of co-authors of Irene Feingold

This figure shows the co-authorship network connecting the top 25 collaborators of Irene Feingold. A scholar is included among the top collaborators of Irene Feingold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irene Feingold. Irene Feingold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Morris, Robert, Ronald C. Bernotas, Jeremy Travins, et al.. (2010). Synthesis of 4-(3-biaryl)quinoline sulfones as potent liver X receptor agonists. Bioorganic & Medicinal Chemistry Letters. 20(9). 2903–2907. 12 indexed citations
2.
Vera, Matthew D., Joseph T. Lundquist, Murty Chengalvala, et al.. (2010). Synthesis and biological evaluation of piperazinyl heterocyclic antagonists of the gonadotropin releasing hormone (GnRH) receptor. Bioorganic & Medicinal Chemistry Letters. 20(8). 2512–2515. 6 indexed citations
3.
Lundquist, Joseph T., Douglas C. Harnish, John F. Mehlmann, et al.. (2010). Improvement of Physiochemical Properties of the Tetrahydroazepinoindole Series of Farnesoid X Receptor (FXR) Agonists: Beneficial Modulation of Lipids in Primates. Journal of Medicinal Chemistry. 53(4). 1774–1787. 42 indexed citations
4.
Hu, Baihua, Rayomand J. Unwalla, Igor Goljer, et al.. (2010). Identification of Phenylsulfone-Substituted Quinoxaline (WYE-672) as a Tissue Selective Liver X-receptor (LXR) Agonist. Journal of Medicinal Chemistry. 53(8). 3296–3304. 32 indexed citations
5.
Hu, Baihua, Michael D. Collini, Elaine Quinet, et al.. (2009). Discovery and SAR of cinnolines/quinolines as liver X receptor (LXR) agonists with binding selectivity for LXRβ. Bioorganic & Medicinal Chemistry. 17(10). 3519–3527. 43 indexed citations
6.
Quinet, Elaine, Michael Basso, Anita Halpern, et al.. (2009). LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse. Journal of Lipid Research. 50(12). 2358–2370. 82 indexed citations
7.
Singhaus, Robert R., Ronald C. Bernotas, Robert J. Steffan, et al.. (2009). 3-(3-Aryloxyaryl)imidazo[1,2-a]pyridine sulfones as liver X receptor agonists. Bioorganic & Medicinal Chemistry Letters. 20(2). 521–525. 57 indexed citations
8.
Travins, Jeremy, Ronald C. Bernotas, David H. Kaufman, et al.. (2009). 1-(3-Aryloxyaryl)benzimidazole sulfones are liver X receptor agonists. Bioorganic & Medicinal Chemistry Letters. 20(2). 526–530. 27 indexed citations
9.
Blass, Benjamin E., Andrew Fensome, Eugene J. Trybulski, et al.. (2009). Selective Kv1.5 Blockers: Development of (R)-1-(Methylsulfonylamino)-3-[2-(4-methoxyphenyl)ethyl]-4-(4-methoxyphenyl)-2-imidazolidinone (KVI-020/WYE-160020) as a Potential Treatment for Atrial Arrhythmia. Journal of Medicinal Chemistry. 52(21). 6531–6534. 16 indexed citations
10.
Hauze, Diane B., Murty Chengalvala, Joshua E. Cottom, et al.. (2009). Small molecule antagonists of the gonadotropin-releasing hormone (GnRH) receptor: Structure–activity relationships of small heterocyclic groups appended to the 2-phenyl-4-piperazinyl-benzimidazole template. Bioorganic & Medicinal Chemistry Letters. 19(7). 1986–1990. 9 indexed citations
11.
Hu, Baihua, Rayomand J. Unwalla, Michael D. Collini, et al.. (2009). Quinoline-3-carboxamide containing sulfones as liver X receptor (LXR) agonists with binding selectivity for LXRβ and low blood–brain penetration. Bioorganic & Medicinal Chemistry Letters. 20(2). 689–693. 19 indexed citations
12.
Pelletier, Jeffrey C., Murty Chengalvala, Joshua E. Cottom, et al.. (2009). Discovery of 6-({4-[2-(4-tert-Butylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl}methyl)quinoxaline (WAY-207024): An Orally Active Antagonist of the Gonadotropin Releasing Hormone Receptor (GnRH-R). Journal of Medicinal Chemistry. 52(7). 2148–2152. 11 indexed citations
13.
DiBlasio-Smith, Elizabeth A., Maya Arai, Elaine Quinet, et al.. (2008). Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells. Journal of Translational Medicine. 6(1). 59–59. 34 indexed citations
14.
Pelletier, Jeffrey C., Murty Chengalvala, Irene Feingold, et al.. (2008). 2-Phenyl-4-piperazinylbenzimidazoles: Orally active inhibitors of the gonadotropin releasing hormone (GnRH) receptor. Bioorganic & Medicinal Chemistry. 16(13). 6617–6640. 24 indexed citations
15.
Nambi, Ponnal, Michael Basso, Liang Chen, et al.. (2007). Abstract 1453: LXR-623, a novel Liver X Receptor modulator, displays neutral lipid effects in Cholesteryl Ester Transfer Protein-expressing species and inhibits atherosclerotic lesion progression in Low Density Lipoprotein receptor knockout mice. Circulation. 116. 3 indexed citations
16.
Feingold, Irene, Penelope A. Longhurst, & Howard D. Colby. (1993). Regulation of adrenal and hepatic α-tocopherol content by androgens and estrogens. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1176(1-2). 192–196. 25 indexed citations
17.
Feingold, Irene & Howard D. Colby. (1992). Sex Differences in Adrenal and Hepatic α-Tocopherol Concentrations in Rats. Pharmacology. 44(2). 113–116. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Wilhelmsson Breakdown of academic impact, for papers by Paul K. Spearing Breakdown of academic impact, for papers by Colin J. Theobald Breakdown of academic impact, for papers by JeanMarie Lisnock Breakdown of academic impact, for papers by Alan D. Adams Breakdown of academic impact, for papers by Harold E. Osborne Breakdown of academic impact, for papers by Kazuyoshi Tomita Breakdown of academic impact, for papers by Annika Goos‐Nilsson Breakdown of academic impact, for papers by Tomoyuki Fujioka Breakdown of academic impact, for papers by Lena Schultz
Rankless by CCL
2026